Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07361783Not ApplicableRecruiting

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

Role: collaborator

NCT07240467Phase 2Not Yet Recruiting

Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness

Role: collaborator

NCT06455670Not ApplicableNot Yet Recruiting

Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD

Role: collaborator

NCT04501198Not ApplicableUnknown

Moxibustion Combined With Characteristic Lifestyle Intervention of Traditional Chinese Medicine in the Treatment of Abdominal Obesity: A Study Protocol for a Randomized Controlled Trial

Role: collaborator

All 5 trials loaded